The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure

NCT00549536 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2008-07-04

No results posted yet for this study

Summary

Increased levels of intracellular calcium are thought to diminish maximal cellular response to insulin and induce insulin resistance. Also, both hypertension and diabetes are thought to be conditions of altered intracellular ionic state. The aim of the present study is to investigate the possible effect of oral calcium supplementation on intracellular ions, insulin sensitivity, 24-h blood pressure and sodium/hydrogen exchanger activity in patients with type 2 diabetes and essential hypertension.

Conditions

Interventions

DIETARY_SUPPLEMENT

tablets each containing of 1000mg elemental calcium (Mega-Calcium Sandoz)

1500 mg of elemental calcium per day.

Sponsors & Collaborators

  • Hellenic Society of Hypertension

    collaborator OTHER
  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Anastasios N. Lasaridis, MD, PhD · 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece

  • Maria I. Pikilidou, MD, MSc · 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00549536 on ClinicalTrials.gov